MINIDIAB Tablet Ref.[50309] Active ingredients: Glipizide

Source: Pharmaceutical Benefits Scheme (AU) Revision Year: 2020 Publisher: Pfizer Australia Pty Ltd, Level 17, 151 Clarence Street, Sydney NSW 2000, Toll Free Number: 1800 675 229, www.pfizer.com.au

Product name and form

MINIDIAB – Glipizide.

Pharmaceutical Form
White, round, biconvex, scored tablets.

Qualitative and quantitative composition

Each tablet contains 5 mg of glipizide.

Excipient(s) with known effect: lactose monohydrate.

For the full list of excipients, see Section 6.1 List of excipients.

Physicochemical properties

Glipizide is a whitish, odourless powder with a pKa of 5.9. It is insoluble in water and alcohols, but soluble in 0.1 N NaOH; it is freely soluble in dimethylformamide.

MINIDIAB (glipizide) is an oral blood-glucose lowering drug of the sulphonylurea class. The chemical name of glipizide is 1-cyclohexyl-3-{4-[2-(5-methylpyrazine-2-carboxamido)ethyl]-benzene-sulphonyl} urea. The molecular formula is C₂₁H₂₇N₅O₄S, molecular weight is 445.5, and the structural formula is shown below:

Chemical structure

CAS number: 29094-61-9

Active Ingredient	Description
Glipizide	Glipizide is an oral blood-glucose-lowering drug of the sulfonylurea class. The primary mode of action of glipizide is the stimulation of insulin secretion from the beta-cells of pancreatic islet tissue.

List of Excipients
Cellulose Maize starch Stearic acid Lactose monohydrate

Pack sizes and marketing

The tablets are blister packed and available in pack size of 100 tablets.

Marketing authorization holder

Pfizer Australia Pty Ltd, Level 17, 151 Clarence Street, Sydney NSW 2000, Toll Free Number: 1800 675 229, www.pfizer.com.au

Marketing authorization dates and numbers

23 September 1991

Drugs

Drug	Countries
MINIDIAB	Austria, Australia, Brazil, Hong Kong, New Zealand, Singapore, South Africa

Next: Usage >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.